EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Potential and challenges of clinical high‐dimensional flow cytometry: A call to action

Thomas Liechti, Iva Lelios, Aaron Schroeder, Vilma Decman, Christele Gonneau, Christopher Groves, Cherie Green, Enrique Gomez Alcaide iD

Cytometry Part A · 2024-11 · 105 (11) · 829-837

DOI: 10.1002/cyto.a.24902 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cytometry Part A, online erschienen am 23.10.2024. Verfasst von Thomas Liechti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine, Genentech, San Francisco, California, USA. Hauptthemen laut MEDLINE: Flow Cytometry, Biomarkers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical biomarker strategies increasingly integrate translational research to gain new insights into disease mechanisms or to define better biomarkers in clinical trials. High‐dimensional flow cytometry (HDFCM) holds the promise to enhance the exploratory potential beyond traditional, targeted biomarker strategies. However, the increased complexity of HDFCM poses several challenges, which need to be addressed in order to fully leverage its potential and to align with current regulatory requirements in clinical flow cytometry. These challenges include among others extended timelines for assay development and validation, the necessity for extensive knowledge in HDFCM, and sophisticated data analysis strategies. However, no guidelines exist on how to manage such challenges in adopting clinical HDFCM. Our CYTO 2024 workshop “Potential and challenges of clinical high‐dimensional flow cytometry” aimed to find consensus across the pharmaceutical industry and broader scientific community on the overall benefits and most urgent challenges of HDFCM in clinical trials. Here, we summarize the insights we gained from our workshop. While this report does not provide a blueprint, it is a first step in defining and summarizing the most pressing challenges in implementing HDFCM in clinical trials. Furthermore, we compile current efforts with the goal to overcome some of these challenges. As such we bring the scientific community and health authorities together to build solutions, which will accelerate and simplify the full adoption of HDFCM in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryBiomarkersHumansTranslational Research, BiomedicalClinical Trials as Topic

Stichwörter der Autor:innen

assay validationbiomarkersclinical trialshigh‐dimensional flow cytometryspectral flow cytometrystandardizationunsupervised data analysis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Translational Medicine, Genentech, San Francisco, California, USA.
  • Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Cellular Biomarkers, GSK, Collegeville, Pennsylvania, USA.
  • Labcorp, Geneva, Switzerland.
  • Translational Science and Innovation Laboratory, Q2 Solutions, Durham, North Carolina, USA.
  • Translational Science, Ozette, Seattle, Washington, USA.

ORCID-Profile: Enrique Gomez Alcaide

Zitieren

APA

Liechti, T., Lelios, I., Schroeder, A., Decman, V., Gonneau, C., Groves, C., Green, C., & Alcaide, E. G. (2024). Potential and challenges of clinical high‐dimensional flow cytometry: A call to action. Cytometry Part A, 105(11), 829-837. https://doi.org/10.1002/cyto.a.24902

Vancouver

Liechti T, Lelios I, Schroeder A, Decman V, Gonneau C, Groves C, et al. Potential and challenges of clinical high‐dimensional flow cytometry: A call to action. Cytometry Part A. 2024;105(11):829-837. doi:10.1002/cyto.a.24902

BibTeX
@article{Liechti2024,
  author = {Liechti, Thomas and Lelios, Iva and Schroeder, Aaron and Decman, Vilma and Gonneau, Christele and Groves, Christopher and Green, Cherie and Alcaide, Enrique Gomez},
  title = {Potential and challenges of clinical high‐dimensional flow cytometry: A call to action},
  journal = {Cytometry Part A},
  year = {2024},
  volume = {105},
  number = {11},
  pages = {829--837},
  doi = {10.1002/cyto.a.24902}
}
Kostenlos starten →